Refine by
Patient Data Articles & Analysis
317 news found
Hemostemix Inc. (TSX-V: HEM; OTCQB: HMTXF; FSE: 2VF0), an autologous stem cell company developing and commercializing VesCell™ (ACP-01), announces the appointment of a seasoned commercial team encompassing marketing, sales, e-commerce and patient care communications, in compliance with federal and state regulations. The appointments enable Hemostemix to sell VesCell™ in Florida to ...
Summary Did you know that between 64% and 93% of dentists and dental hygienists experience work-related musculoskeletal pain?1 The solution to working pain-free might lie in better ergonomics education. Ergonomics is vital in dentistry, where professionals often work in static, awkward positions that can lead to musculoskeletal disorders and chronic pain. Proper ergonomic practices can help ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, today announced the next step in the partnership between the Company and Genomenon, a leading genomic intelligence company, to support better, data-driven outcomes in the rare disease and oncology fields. ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, will unveil new research at the European Society for Medical Oncology (ESMO) 2024. ...
Since launching the first generation of SOPHiA DDM™ in 2015, the Platform has been at the forefront of these innovations, accelerating the practice of data driven medicine globally as a leading platform in healthcare for using data to improve patient care. ...
“We are excited to see how Modus Plan can improve the precision of brain surgeries and enhance patient outcomes,” said Cameron Piron, Chief Strategy Officer, President, and Cofounder of Synaptive Medical. ...
At the 2024 ASCO® Annual Meeting, the company is presenting new data on the xM test with an analytically improved pipeline. The research demonstrates a clinical sensitivity at a landmark of 61.1% and a robust surveillance performance with longitudinal sensitivity of 83.3% and specificity of 89.5% across stage II/III CRC patients. xM MRD results predict ...
ByTempus
Prophecy Market Research says it could reach US$ 508.7 billion by 2034. From data to diagnostics and imaging, drug development and discovery, early intervention and predictive analytics, remote patient monitoring and robotics, AI is revolutionizing healthcare as we know it. ...
As we look into the new year, the healthcare landscape in the UK is undergoing a number of changes. From digital transformation to evolving regulations, healthcare organisations across the UK are facing a number of challenges in 2024. We delve into five potential challenges confronting healthcare providers across the UK to help them prepare for the year ahead. ...
Caresyntax CDaaS helps partners overcome the opacity that surrounds the patient experience in the OR. While modern electronic medical records (EMR) and data warehouses provide insight to high level data like demographics, billing, and reimbursement claims, there is less discrete data output from the actual OR experience. ...
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program, a co-sell program for AWS partners that provide software solutions that run on or integrate with AWS. ...
This method uses state-of-the-art instruments that precisely measure key flow properties, including the angle of repose, bulk density, and flow rate. By obtaining accurate data on these parameters, CD Formulation aims to empower pharmaceutical companies to optimize their formulation processes. ...
It can aid in the diagnosis of asthma and COPD and can also help identify patients who are at risk of progression to COPD. [1] The tremoflo® C-100 assesses respiratory function through simple tidal breathing and can be a valuable tool when compiling a detailed picture of respiratory function. It is particularly useful in enabling the very young, frail, or ...
Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, taking place in Washington. ...
Picosecond laser technology is a highly sought-after treatment in the field of medical aesthetics that can effectively treat all types of skin blemishes. The treatment of blemishes has long been one of the most difficult problems in the field of medical aesthetics and with the use of picosecond laser technology, there is finally a simple and effective solution to this problem. Bvlaser is a ...
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company’s BVA-100 diagnostic in optimizing individualized therapy for heart failure patients. Data were presented at the Technology Heart Failure Therapeutics Conference, which focuses on device ...
Oak Ridge, TN – March 23, 2023 — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company’s BVA-100 diagnostic in optimizing individualized therapy for heart failure patients. Data were presented at the Technology Heart Failure ...
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new pilot randomized control trial (RCT) data from Duke Heart validating the greater accuracy of the Company’s BVA-100 diagnostic in optimizing decongestion therapy for heart failure patients and pointed to a strong signal toward reducing hospital length ...
Oak Ridge, TN – March 23, 2023 — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new pilot randomized control trial (RCT) data from Duke Heart validating the greater accuracy of the Company’s BVA-100 diagnostic in optimizing decongestion therapy for heart failure patients and pointed to ...
Dr. Ali Tinazli is the CEO of lifespin.health and has 15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP). Obesity rates continue to climb alongside a $254.9 billion global weight loss products and services market. Supplements, smartphone weight loss apps, diet plans and exercise programs are widely available to consumers, yet the World Obesity Federation projects that 1 ...